September 5-8, 2024 | Cape Cod, MA |
R. Corey Waller, MD, MS, DFASAM, is board-certified in addiction and emergency medicine with extensive experience at the local/state/national levels. He works with the American Society of Addiction Medicine (ASAM) and related organizations to advance the evidence-based practice of treatment and recovery for individuals affected by addiction. A nationally recognized expert in substance use disorder (SUD), he is editor-in-chief of The ASAM Criteria. As BrightView’s CMO, he oversees medical, behavioral and nursing teams education, practice standards, and care delivery. By engaging and leading BrightView’s providers, he drives service quality, care integration, and the delivery of consistent patient outcomes. Prior to joining BrightView, Dr. Waller was managing director of the HMA Institute on Addiction, where he was responsible for consultation and development of addiction treatment systems for hospitals, primary care practices, justice-involved populations, and addiction treatment providers. He also serves as senior medical director for education and policy at the National Center for Complex Health and Social Needs (National Center) and chief of pain medicine at Spectrum Health System in Grand Rapids, MI. Additionally, he oversaw the development of core competencies for addiction treatment in the labor and delivery unit and the neonatal abstinence syndrome treatment algorithm for the Level 1 neonatal ICU. Dr. Waller earned his master’s degree in biology, with a neuro-molecular focus at Southwest Texas State University and his medical degree at the University of Texas Health Science Center. He completed his emergency medicine residency at Thomas Jefferson University and is board-certified in emergency medicine and addiction medicine.